Rating History for Halozyme Therapeutics (halo) by Leerink

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/7/2026 David Risinger Upgrade Outperform
(Market Perform)
110.00
(83.00)
85.76
(104.89)
22.31% Details